Pulmonx Shares Jump After Leadership Shakeup

Dow Jones10-28
 

By Freddy Sebastian

Shares of medical-technology company Pulmonx gained after it shook up its leadership, bringing back former executives at the helm.

Pulmonx's shares jumped nearly 33% to $2.07 in after-hours trading on Monday.

The company said it re-appointed Glen French as its president and chief executive and Derrick Sung as chief operating officer and chief financial officer, replacing Steve Williamson and Mehul Joshi, respectively, effective Nov. 3.

The company said Williamson and Joshi will serve in advisory capacities through Dec. 1 for a transition and their resignations aren't due to any disagreements with Pulmonx.

Separately, the company said it expects third-quarter revenue at $21.5 million. Analysts surveyed by FactSet expect revenue of $20.8 million.

Pulmonx expects to release quarterly results on Nov. 12.

Write to Freddy Sebastian at freddy.sebastian@wsj.com

 

(END) Dow Jones Newswires

October 27, 2025 18:39 ET (22:39 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment